By Lewis Krauskopf NEW YORK | Fri May 6, 2011 4:15pm EDT NEW YORK (Reuters) – Healthcare funds posted nearly 20 percent gains over the past year — and have outperformed all other sectors in 2011 — but many investors may have missed out on the profits as they worried over the fallout from the U.S. healthcare overhaul. Money flow data show that about $5.5 billion moved out of U.S.-based healthcare and biotechnology funds over the past year, more outflows than virtually any other equity sector, according to Lipper, a Thomson Reuters company that tracks mutual fund data. That represents nearly 12 percent of the $47.2 billion currently in healthcare funds, according to the Lipper data, which was prepared for the Reuters Health Summit that begins Monday in New York. Investors were uneasy buying stocks last year with the 2008 market meltdown still fresh in their minds, said Tom Roseen, a senior analyst with Lipper. “People were ducking for cover and were waiting to see what was going to happen,” Roseen said. “Even though we had a grand 2009 and a really good 2010, people were avoiding going into equities.” With uncertainty tied to the overhaul of health insurance coverage under President Barack Obama, Roseen said, investors were wary of “a subset as small as healthcare.” Even with their gains, healthcare funds lagged the one-year returns of sector funds such as precious metals (up 40.7 percent) and natural resources (up 32.8 percent). But that has changed more recently. U.S. and global healthcare funds are up 14.8 percent and 14.2 percent, respectively, in 2011, making them the top two performing groups of the 20 sector funds tracked by Lipper. U.S. funds hold at least 75 percent in U.S. healthcare stocks, while global funds have 75 percent or less in U.S. holdings. Both healthcare fund groups rose nearly 7 percent in April alone, which also topped the pack. And some money has come back recently to healthcare: $750 million returned in the month of March to U.S. funds. Healthcare funds more invested in international stocks, however, saw outflows of $186 million in March. Liu-Er Chen, portfolio manager for the Delaware Healthcare Fund, said healthcare’s outperformance is only just beginning. Investors are more comfortable with the ramifications of the U.S. health law, while valuations are cheap for drugmakers and health insurers, among others, said Chen, whose fund scored the highest returns over the past three years of those healthcare funds tracked by Lipper. Plus, he said, demographic trends such as an aging population as well as an emerging middle class in developing markets, combined with unmet medical needs, favor growth. “You have everything you need,” Chen said. “You get improving regulatory environment, you get cheap valuation, you get plenty of growth prospects if you do your fundamentals.” STILL DEFENSIVE In the past 10 years, global and U.S. healthcare funds have posted similar returns, with U.S. funds slightly ahead. The average annual return was 4.6 percent for global funds and 4.7 percent for U.S. funds. Over five years, the annual returns were 5 percent for global and 6.1 percent for U.S. funds. The three-year average annual returns were 7.2 percent for global funds and 9.3 percent for U.S. counterparts. Within the top performing funds over the past three years, healthcare stalwarts Pfizer, Merck, Amgen, and Abbott Laboratories are the most common large holdings. Smaller companies, such as InterMune, Endo Pharmaceutical Holdings and Kinetic Concepts also are big holdings in a few of these top-performing funds. Healthcare funds also are retaining defensive qualities — showing fewer losses compared to other equity funds, according to Lipper’s analysis of returns over the past three years. The vast majority of healthcare funds tracked by Lipper scored the highest rating for preservation of capital, a measure of the defensive qualities of funds. “Of the sector equities, this probably has the best ability of mitigating losses in downturns than any other group. I think that’s a positive for the sector,” Roseen said.
Continue reading " Many investors lost out on healthcare gains "